source
- STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreThe number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026STAT · 12d ago↗ source
- Who can access testosterone hormone medication in the U.S.?Wildfire smoke health hazards, a new idea for treating Duchenne, and more health news from Morning RoundsSTAT · 12d ago↗ source
- GSK drops Phase 3 chronic cough drug in a blow to $2B Bellus Health buyoutIn a major stumble for GSK’s $2 billion acquisition of Bellus Health, the UK pharma said Friday it is ending development of camlipixant in refractory chronic cough (RCC) after the drug ...Endpoints · 12d ago↗ source